CLINICAL_TRIALS
trial_result
· 2013-05-17
Clinical Trial Update: Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes [Phase 1]
Summary
Phase 1 open-label, 4-week study of ITCA 650 in adults with Type 2 diabetes mellitus completed; results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Intarcia Therapeutics | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2013-05-17